Septal perforation secondary to Mycobacterium kansasii infection

Journal of Laryngology and Otology

Volumn 117, Issue 12, 2003, Pages 992-994

  Bennett, A M D ^a,b   Patel, N ^a   Kotecha, B ^a   Phil, M ^a   Al Okati, A ^a  

^a Depts of Otolaryngol and Pathology   (United Kingdom)

^b NORFOLK AND NORWICH UNIVERSITY HOSPITAL   (United Kingdom)

Author keywords

Fistula; Mycobacterium Kansasii; Nasal Septum

Indexed keywords

ETHAMBUTOL; ISONIAZID PLUS RIFAMPICIN; PYRAZINAMIDE; PYRIDOXINE; RIFAMPICIN;

ADULT; ARTICLE; BACTERIAL ARTHRITIS; BACTERIAL INFECTION; BRAIN ABSCESS; CASE REPORT; COMPUTER ASSISTED TOMOGRAPHY; DIFFERENTIAL DIAGNOSIS; FEMALE; HUMAN; HUMAN IMMUNODEFICIENCY VIRUS INFECTION; INCIDENCE; LONGEVITY; MOUTH LESION; MYCOBACTERIOSIS; MYCOBACTERIUM KANSASII; NOSE SEPTUM; NOSE SEPTUM PERFORATION; OSTEOMYELITIS; PERICARDITIS; PREVALENCE; SINUSITIS; SKIN DEFECT;

FEMALE; HUMANS; MIDDLE AGED; MYCOBACTERIUM INFECTIONS, ATYPICAL; MYCOBACTERIUM KANSASII; NASAL SEPTUM; NOSE DISEASES; RESPIRATORY TRACT FISTULA;

EID: 0346788859     PISSN: 00222151     EISSN: None     Source Type: Journal    
DOI: 10.1258/002221503322683939     Document Type: Article

References (16)

1. Collman JR, Strong EB. Management of nasal septal perforation. Curr Opin Otolaryngol Head Neck Surg 2000;8:58-62
2. Diamantopoulos II, Jones NS. The investigation of nasal septal perforations and ulcers. J Laryngol Otol 2001;115:541-4
3. French AL, Benator DA, Gordin FM. Non-tuberculous mycobacterial infections. Med Clin N Am 1997;81:369-77
4. Bloch KC, Zwerling L, Pletcher MJ, Hahn JA, Gerberding JL, Ostroff SM et al. Incidence and clinical implications of isolation of Mycobacterium kansasii. Results of a 5-year, population-based study. Ann Intern Med 1998;129:698-704
5. Griffith DE. Mycobacteria as pathogens of respiratory infection. Infect Dis Clin N Am 1998;12:593-611
6. Rauscher CR, Kerby G, Ruth WE. A ten-year clinical experience with Mycobacterium kansasii. Chest 1974;66:17-9
7. Friedman AW, Ike RW. Mycobacterium kansasii septic arthritis in a patient with acquired immune deficiency syndrome. Arthritis Rheum 1993;36:1631-2
8. Moreno F, Sharkey-Mathis PK, Mokulis E, Smith JA. Mycobacterium kansasii pericarditis in patients with AIDS. Clin Infect Dis 1994;19:967-9
9. Bergen GA, Yangco BG, Adelman HM. Central nervous system infection with Mycobacterium kansasii. Ann Intern Med 1993;118:396
10. Naguib MT, Byers JM, Slater LN. Paranasal sinus infection due to atypical mycobacteria in two patients with AIDS. Clin Infect Dis 1994;19:789-91
11. Li C, Szuba MJ, Schuman P, Crane L, Vazquez JA. Mycobacterium kansasii sinusitis in a patient with AIDS. Clin Infect Dis 1994;19:792-3
12. Nuesch R, Battegay M, Zimmerli W, Thumshirn M, Gilli L, Itin PH. Oral manifestation of disseminated Mycobacterium kansasii infection in a patient with AIDS. Dermatology 1996;192:183-4
13. Breathnach A, Levell N, Munro C, Natarajan S, Pedler S. Cutaneous Mycobacterium kansasii infection: Case report and review. Clin Infect Dis 1995; 20:812-7
14. Tortoli E, Simonetti MT, Dionisio D. Nasal Mycobacterium kansasii infection in a patient with acquired immunodeficiency syndrome. Eur J Clin Microbiol Infect Dis 1993;12:564-5
15. Witzig RS, Fazal BA, Mera RM, Mushatt DM, Dejace PM, Greer DL, et al. Clinical manifestations and implications of co-infection with Mycobacterium kansasii and human immunodeficiency virus type 1. Clin Infect Dis 1995;21:77-85
16. Wallace RJ Jr., Dunbar D, Brown B, Onyi G, Dunlap R, Ahn CH, et al. Rifampicin-resistant Mycobacterium kansasii. Clin Infect Dis 1994;18:736-43